9 unknown. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Unknown 9 |
Follow Hyperlipidemia: new trials by email Literature Review of Hyperlipidemia trials Research Report on Hyperlipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound Inclisiran - Carotid Plaque, Hyperlipidemia | Phase 4 | Unknown | First Affiliated Hospital of Xinjiang Medical University | 40 | 2024-09-20 | 2024-09-19 |
| Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab Alirocumab - Atherosclerosis, Hyperlipidemia | Phase 4 | Unknown | Westside Medical Associates of Los Angeles | 35 | 2016-11-01 | 2019-04-26 |
| Nutraceuticals to Improve Lipid Profile in European Countries Non-pharmacologic intervention, Nutraceuticals (Armolipid Plus) - Hyperlipidemia | Phase 4 | Unknown | University of Roma La Sapienza | 100 | 2014-01-01 | 2013-03-07 |
| Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Rosuvastatin - Hyperlipidemia, Coronary Artery Disease | Phase 4 | Unknown | Peking University First Hospital | 600 | 2011-03-01 | 2011-06-27 |
| Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia Simvast CR, Zocor - Chronic Kidney Disease, Hyperlipidemia | Phase 4 | Unknown | Hanmi Pharmaceutical Company Limited | 122 | 2010-12-01 | 2012-03-28 |
| Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients ezetimibe, fenofibrate, pravastatin - HIV, Hyperlipidemia | Phase 4 | Unknown | Ospedale di Circolo - Fondazione Macchi | 60 | 2009-03-01 | 2011-08-02 |
| Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) Rosuvastatin (Crestor) - Hyperlipidemia, Atherosclerosis | Phase 4 | Unknown | Chinese PLA General Hospital | 60 | 2009-03-01 | 2010-05-27 |
| Treatment of Hyperlipidemia and Sexual Dysfunction fenofibrate, Rosuvastatin, fenofibrate + rosuvastatin - Sexual Dysfunction, Hyperlipidemia | Phase 4 | Unknown | University of Campania Luigi Vanvitelli | 300 | 2008-04-01 | 2015-11-18 |
| Japanese Primary Prevention Project With Aspirin Aspirin - Hypertension, Hyperlipidemia | Phase 4 | Unknown | Ministry of Health, Labour and Welfare, Japan | 10000 | 2005-03-01 | 2005-09-26 |
Hyperlipidemias (9) · Atherosclerosis (2) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · HIV Infections (1) · Hypertension (1) · Renal Insufficiency, Chronic (1) · Sexual Dysfunction, Physiological (1)
Dyslipidemias (9) · Lipid Metabolism Disorders (9) · Metabolic Diseases (9) · Nutritional and Metabolic Diseases (9) · Cardiovascular Diseases (4) · Vascular Diseases (4) · Arterial Occlusive Diseases (3) · Arteriosclerosis (3) · Urogenital Diseases (3) · Genital Diseases (2) · Blood-Borne Infections (1) · Chronic Disease (1) · Communicable Diseases (1) · Coronary Disease (1) · Disease Attributes (1)
Rosuvastatin Calcium (3) · Fenofibrate (2) · ALN-PCS (1) · Aspirin (1) · Dietary Supplements (1) · Ezetimibe (1) · Pravastatin (1) · Simvastatin (1) · alirocumab (1)
Chinese PLA General Hospital (1) · First Affiliated Hospital of Xinjiang Medical University (1) · Hanmi Pharmaceutical Company Limited (1) · Ministry of Health, Labour and Welfare, Japan (1) · Ospedale di Circolo - Fondazione Macchi (1) · Peking University First Hospital (1) · University of Campania Luigi Vanvitelli (1) · University of Roma La Sapienza (1) · Westside Medical Associates of Los Angeles (1)
Italy (3) · China (2) · Japan (1) · South Korea (1) · United States (1)
Dario Giugliano, MD,PhD (1) · Francesco Pelliccia, MD (1) · Kyung-mi Park, Ph.D (1) · Norman Lepor, MD (1) · Ping Ye, Doctor (1) · Yasuo Ikeda, MD (1) · Yong Huo, MD (1) · Zhenyan Fu, PhD (1)
PMID 25022285, PMID 25401325, PMID 27165949, PMID 30565155, PMID 38018702